22157.jpg
US YUTIQ Autoimmune Uveitis Market Evaluation Now Available: Comprehensive Insight and Forecast up to 2032
29 févr. 2024 10h50 HE | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "US YUTIQ Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering The expansive analysis...
22157.jpg
Myopia Pipeline Insights Report 2024: Latest Progress in Nearsightedness Therapeutics
27 févr. 2024 11h20 HE | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Myopia - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The healthcare sector has observed a surge in research...
22157.jpg
Retinitis Pigmentosa Pipeline Insight Report 2024: Unveiling New Horizons in Genetic Disorder Therapeutics
27 févr. 2024 11h12 HE | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The global medical community is set to...
Global Thyroid Eye Disease Treatment Market
Thyroid Eye Disease Treatment Market Poised for Significant Growth as Demands Surge, States New 2023-2029 Global Industry Forecast
20 févr. 2024 04h58 HE | Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Thyroid Eye Disease (TED) Treatment Market (2023 Edition): Analysis By Therapeutic Type, Route of Administration, Distribution Channel, By...
22157.jpg
DEXTENZA Drug Insight and U.S. Market Forecast to 2032: Navigating Clinical Trials, Regulatory Milestones, and Market Growth Potential in the Treatment of Acute Ocular Pain
30 janv. 2024 10h48 HE | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "United States DEXTENZA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
22157.jpg
INVELTYS (loteprednol etabonate/KPI-121) Drug Insight and U.S. Market Analysis, 2023-2032: Projected to Dominate the Acute Ocular Pain (AOP) Sector
29 janv. 2024 12h51 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States INVELTYS Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an...
22157.jpg
Ophthalmic Drugs Contract Manufacturing Market Analysis 2023-2033: Cost Efficiencies Provided by Specialized Manufacturing Partners Driving the Industry
26 janv. 2024 11h17 HE | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Contract Manufacturing Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The ophthalmic drugs...
22157.jpg
Global Macular Degeneration Treatment Market Forecast to 2031: Breakthrough in Durable Anti-VEGF Drugs Redefines Patient Care with Less Frequent Dosing
26 janv. 2024 06h27 HE | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Macular Degeneration Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
22157.jpg
Non-Infectious Macular Edema Treatment Market Set to Experience Exponential Growth by 2031 with Prominent Demand for Corticosteroids in North America and Europe
25 janv. 2024 06h19 HE | Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Non-infectious Macular Edema Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
22157.jpg
Global Vitreo Retinal Surgery Devices Pipeline Research Report 2023 Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
24 janv. 2024 15h13 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Vitreo Retinal Surgery Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023...